Cdk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CDK2 (Cyclin-Dependent Kinase 2) is a serine/threonine kinase that plays central roles in cell cycle regulation, particularly at the G1/S and S phase transitions. CDK2 forms complexes with cyclin E and cyclin A to drive cells through S phase. While CDK2 is essential for cell proliferation, it also has important functions in post-mitotic neurons related to synaptic plasticity, DNA repair, and neuronal survival .
| Attribute |
Value |
| Gene Symbol |
CDK2 |
| Protein Name |
Cyclin-Dependent Kinase 2 |
| Alternative Names |
CDK2, p33 |
| UniProt ID |
P24941 |
| Molecular Weight |
~34 kDa |
| Protein Family |
CDK family |
| Tissue Distribution |
Broad, highest in proliferating cells |
CDK2 has canonical CDK structure:
- N-terminal kinase domain — Catalytic activity
- C-terminal activation segment — Contains Thr160 phosphorylation site
- Cyclin-binding interface — Binds cyclin E and cyclin A
- Substrate recognition site — Recognizes RXL motif
CDK2 activation requires:
- Cyclin binding (E or A)
- Thr160 phosphorylation by CAK
- Removal of inhibitory phosphorylation
CDK2 regulates:
- G1/S transition — With cyclin E, phosphorylates RB
- S phase progression — With cyclin A, drives DNA replication
- Centrosome duplication — Regulates centrosome cycle
- Histone synthesis — Activates histone gene expression
In neurons:
- Synaptic plasticity — Regulates AMPA receptor trafficking
- DNA repair — Involved in neuronal DNA damage response
- Metabolic regulation — Controls neuronal metabolism
- Survival signaling — Pro-survival and pro-death roles
CDK2 is implicated in AD:
- Cell cycle re-entry — Neurons inappropriately re-enter cell cycle
- Tau phosphorylation — CDK2 can phosphorylate tau
- Synaptic dysfunction — Alters synaptic plasticity
- Aβ toxicity — Activated by Aβ oligomers
CDK2 is part of the "cell cycle hypothesis" of AD .
- Cell cycle activation — Seen in PD substantia nigra
- Dopaminergic degeneration — Contributes to neuron loss
- Mitochondrial dysfunction — Interacts with PINK1/Parkin pathway
¶ Stroke and Brain Injury
- DNA damage response — CDK2 activates DNA repair
- Cell death pathways — Can promote or inhibit apoptosis
CDK2 as a therapeutic target:
- Cancer — CDK2 inhibitors in development
- Neurodegeneration — Modulating CDK2 activity
- Combination therapy — Synergy with CDK4/6 inhibitors
- PMID:8286350 — CDK2 structure and activation
- PMID:10625657 — CDK2 in cell cycle
- PMID:12756245 — CDK2/Cyclin E structure
- PMID:15857886 — CDK2 in neuronal functions
- PMID:18559509 — CDK2 in Alzheimer's disease
- PMID:21479819 — CDK2 and neurodegeneration
The study of Cdk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.